Innotox / INNOTOX 100 units. It is an innovative drug (botulinum toxin) type A developed by the South Korean company Medytox Inc.
This drug has gained tremendous popularity in clinics in South Korea and Japan due to several advantages:
1) Structure of the drug: Innotox is available in a new liquid phase, so it does not require dilution.
2) Composition: The improved formula of the preparation does not contain proteins, albumin, or gelatin, compared with other similar drugs.
3) Temperature conditions: In contrast to solid-phase preparations, this product is insensitive to temperature extremes. However, it is recommended that it be kept in the refrigerator until use. The opened bottle can be stored in the fridge at 2 to 8 degrees for 72 hours.
4) Diffusion: has the most minor diffusion among all botulinum toxins.
5) Effect: The effect lasts up to 8 months during procedures, in contrast to other botulinum toxins, which last up to 4 months.
Indications
- blepharospasm;
- hemifacial spasm;
- cervical dystonia (spastic torticollis);
- focal spasticity of the wrist and hand in stroke patients;
- paralytic strabismus (squint);
- local muscle spasm in cerebral palsy in children aged two years and older;
- correction of facial wrinkles.
CONTRAINDICATIONS, COMPLICATIONS, POSSIBLE SIDE EFFECTS:
hypersensitivity to the components of the composition;
pregnancy and lactation;
inflammatory processes on the skin in the target area;
bleeding disorders;
herpes, as well as any infectious and chronic systemic diseases in the acute stage;
fever;
diabetes;
oncological diseases;
pronounced hernial protrusions on the lower and upper eyelids;
myasthenia gravis (Myasthenia Gravis) - an autoimmune disease that causes chronic muscle fatigue syndrome;
age before 18 and after 65 years.
